<DOC>
	<DOCNO>NCT01123135</DOCNO>
	<brief_summary>This randomize , double blind placebo control trial period 3 month . Study subject randomize 2 group : Those receive drug ( 1gm estrogen vaginal cream [ EVC ] bed time 3 time week ) , receive placebo .</brief_summary>
	<brief_title>The Effect Vaginal Estrogen Cream Subjective Objective Symptoms Urodynamic Stress Incontinence</brief_title>
	<detailed_description>1 . This randomized , double blind placebo control trial period 3 month . Study subject randomize 2 group : Those receive drug ( 1gm estrogen vaginal cream [ EVC ] bed time 3 time week ) , receive placebo . Study subject patient diagnosed stress urinary incontinence urodynamic evaluation . They fill IIQ-7 UDI-6 validate questionnaire routine patient evaluate stress incontinence . After enrollment informed consent , initial screen include Pap smear vaginal maturation . 2 . Subjects see 4 , 8 12 week . At visit , turn medication tube receive new study medication . They also screen adverse reaction study medication visit . 3 . At end study period , subject fill validated questionnaire beginning study also urethral pressure profile PAP smear repeat . 4 . The urethral pressure profile part standard complex urodynamic testing patient undergo evaluation diagnosis urodynamic stress incontinence . Urethral Pressure Profile technique use provide information ability urethra prevent leakage . The Urethral Pressure Profile specific study , special design catheter pull urethra slow , continuous rate . The result `` bell shape '' curve illustrate function urethra begin bladder neck meatus . 5 . The placebo cream pharmacologically inert formulation package similarly active premarin cream visually indistinguishable active drug study subject researcher .</detailed_description>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>English speaking Postmenopausal woman ( No menses minimum period 1 year ) Urodynamic stress urinary incontinence History breast uterine cancer History venous thrombolic event Hormone replacement therapy within 3 month study Sensitivity allergy premarin cream Current use medication urge stress incontinence Prior surgery stress incontinence Overactive bladder Detrussor instability Active vaginal/ bladder infection ( patient treat negative test cure order enrol study ) History pelvic vaginal radiation therapy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>urodynamic stress incontinence</keyword>
	<keyword>postmenopausal woman</keyword>
</DOC>